Skip to content
2000
Volume 24, Issue 2
  • ISSN: 2211-3525
  • E-ISSN: 2211-3533

Abstract

Mpox, also known as monkeypox, is a zoonotic virus belonging to the orthopoxvirus genus. Predominantly, it is found in Central and West Africa, and the virus has emerged as a global health concern due to recent outbreaks. Mpox presents with symptoms similar to smallpox, including fever, rash, and lymphadenopathy, but is generally less severe. Transmission occurs through contact with infected animals, humans, or contaminated surfaces. Understanding Mpox morphology, transmission dynamics, and clinical symptoms is crucial for effective prevention, diagnosis, and treatment.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aia/10.2174/0122113525395043250625113321
2025-07-04
2026-03-09

  • From This Site

    /content/journals/aia/10.2174/0122113525395043250625113321
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. LimC.K. RobertsJ. MosoM. LiewK.C. TaoukM.L. WilliamsE. TranT. SteinigE. CalyL. WilliamsonD.A. Mpox diagnostics: Review of current and emerging technologies.J. Med. Virol.2023951e2842910.1002/jmv.28429 36571266
     [Google Scholar]
  2. CabanillasB. MurdacaG. GuemariA. TorresM.J. AzkurA.K. AksoyE. VitteJ. de las VecillasL. GiovanniniM. Fernández-SantamariaR. CastagnoliR. OrsiA. AmatoR. GibertiI. CatalàA. AmbrozejD. SchaubB. Tramper-StrandersG.A. NovakN. NadeauK.C. AgacheI. AkdisM. AkdisC.A. A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak.Allergy202378363966210.1111/all.15633 36587287
     [Google Scholar]
  3. PucaE. ShapoL. For how long can monkeypox reach the Balkan region?Travel Med. Infect. Dis.20224910238210.1016/j.tmaid.2022.102382 35700882
     [Google Scholar]
  4. ZhuF. LiL. CheD. Monkeypox virus under COVID-19: Caution for sexual transmission – Correspondence.Int. J. Surg.202210410676810.1016/j.ijsu.2022.106768 35811013
     [Google Scholar]
  5. CostelloV. SowashM. GaurA. CardisM. PasiekaH. WortmannG. RamdeenS. Imported monkeypox from international traveler, Maryland, USA, 2021.Emerg. Infect. Dis.20222851002100510.3201/eid2805.220292 35263559
     [Google Scholar]
  6. AdenD. ZaheerS. KumarR. RangaS. Monkeypox (Mpox) outbreak during COVID-19 pandemic—Past and the future.J. Med. Virol.2023954e2870110.1002/jmv.28701 36951352
     [Google Scholar]
  7. AlakunleE.F. OkekeM.I. Monkeypox virus: A neglected zoonotic pathogen spreads globally.Nat. Rev. Microbiol.202220950750810.1038/s41579‑022‑00776‑z 35859005
     [Google Scholar]
  8. AzkurA.K. AksoyE. Akdi̇şC. Monkeypox and other zoonotic poxviruses.Ankara Univ. Vet. Fak. Derg.202269444545910.33988/auvfd.1146405
     [Google Scholar]
  9. SrivastavaS. Laxmi SharmaK. SridharS.B. TalathS. ShareefJ. MehtaR. SatapathyP. SahR. Clade Ib: A new emerging threat in the Mpox outbreak.Front. Pharmacol.202415150415410.3389/fphar.2024.1504154 39749207
     [Google Scholar]
  10. Multi-country outbreak of mpox, external situation report #48 - 10 March 2025.2025Available from: https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report--48---10-march-2025
  11. LuJ. XingH. WangC. TangM. WuC. YeF. YinL. YangY. TanW. ShenL. Mpox (formerly monkeypox): Pathogenesis, prevention and treatment.Signal Transduct. Target. Ther.20238145810.1038/s41392‑023‑01675‑2 38148355
     [Google Scholar]
  12. AnwarF. HaiderF. KhanS. AhmadI. AhmedN. ImranM. RashidS. RenZ.G. KhattakS. JiX.Y. Clinical manifestation, transmission, pathogenesis, and diagnosis of monkeypox virus: A comprehensive review.Life202313252210.3390/life13020522 36836879
     [Google Scholar]
  13. LumF.M. Torres-RuestaA. TayM.Z. LinR.T.P. LyeD.C. RéniaL. NgL.F.P. Monkeypox: Disease epidemiology, host immunity and clinical interventions.Nat. Rev. Immunol.2022221059761310.1038/s41577‑022‑00775‑4 36064780
     [Google Scholar]
  14. YiX.M. LeiY.L. LiM. ZhongL. LiS. The monkeypox virus-host interplays.Cell. Insight20243510018510.1016/j.cellin.2024.100185 39144256
     [Google Scholar]
  15. MitjàO. OgoinaD. TitanjiB.K. GalvanC. MuyembeJ.J. MarksM. OrkinC.M. Monkeypox.Lancet202340110370607410.1016/S0140‑6736(22)02075‑X 36403582
     [Google Scholar]
  16. FangD. LiuY. DouD. SuB. The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies.Virol. Sin.202439570971810.1016/j.virs.2024.08.008 39181538
     [Google Scholar]
  17. HettaH.F. AlharbiA.A. AlsharifS.M. AlkindyT.T. AlkhamaliA. AlbalawiA.S. SayedH.H. MohamedM.E.A. MohammedY.A. RamadanY.N. SayadR. Mpox virus infection and vaccination: Immunopathogenesis and exploring the link to neuropsychiatric manifestations.Immunology20244457860010.3390/immuno4040034
     [Google Scholar]
  18. HammerQ. RückertT. RomagnaniC. Natural killer cell specificity for viral infections.Nat. Immunol.201819880080810.1038/s41590‑018‑0163‑6 30026479
     [Google Scholar]
  19. GuoZ. ZhangZ. PrajapatiM. LiY. Lymphopenia caused by virus infections and the mechanisms beyond.Viruses2021139187610.3390/v13091876 34578457
     [Google Scholar]
  20. DavidoB. D’anglejanE. JourdanJ. RobinaultA. DavidoG. Monkeypox 2022 outbreak: Cases with exclusive genital lesions.J. Travel Med.2022296taac07710.1093/jtm/taac077 35699601
     [Google Scholar]
  21. HenryB. CheruiyotI. VikseJ. MutuaV. KipkorirV. BenoitJ. PlebaniM. BragazziN. LippiG. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: A meta-analysis.Acta Biomed.2020913e202000810.23750/abm.v91i3.10217 32921706
     [Google Scholar]
  22. YounanP. SantosR.I. RamanathanP. IampietroM. NishidaA. DuttaM. AmmosovaT. MeyerM. KatzeM.G. PopovV.L. NekhaiS. BukreyevA. Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection.PLoS Pathog.20191510e100806810.1371/journal.ppat.1008068 31648236
     [Google Scholar]
  23. PengX. OuyangJ. IsnardS. LinJ. FombuenaB. ZhuB. RoutyJ.P. Sharing CD4+ T cell loss: When COVID-19 and HIV collide on immune system.Front. Immunol.20201159663110.3389/fimmu.2020.596631 33384690
     [Google Scholar]
  24. HernaezB. AlcamíA. Poxvirus immune evasion.Annu. Rev. Immunol.202442155158410.1146/annurev‑immunol‑090222‑110227 38941604
     [Google Scholar]
  25. BrownB. Immunopathogenesis of Orthopoxviridae: Insights into immunology from smallpox to monkeypox (mpox).Explor. Immunol.2023352555310.37349/ei.2023.00119
     [Google Scholar]
  26. VillarinoA.V. KannoY. O’SheaJ.J. Mechanisms and consequences of Jak–STAT signaling in the immune system.Nat. Immunol.201718437438410.1038/ni.3691 28323260
     [Google Scholar]
  27. HatmalM.M. Al-HatamlehM.A.I. OlaimatA.N. AhmadS. HasanH. Ahmad SuhaimiN.A. AlbakriK.A. Abedalbaset alzyoud, A.; Kadir, R.; Mohamud, R. Comprehensive literature review of monkeypox.Emerg. Microbes Infect.20221112600263110.1080/22221751.2022.2132882 36263798
     [Google Scholar]
  28. HammarlundE. DasguptaA. PinillaC. NororiP. FrühK. SlifkaM.K. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation.Proc. Natl. Acad. Sci. USA200810538145671457210.1073/pnas.0800589105 18796610
     [Google Scholar]
  29. YangL. XieX. TuZ. FuJ. XuD. ZhouY. The signal pathways and treatment of cytokine storm in COVID-19.Signal Transduct. Target. Ther.20216125510.1038/s41392‑021‑00679‑0 34234112
     [Google Scholar]
  30. JohnstonS.C. JohnsonJ.C. StonierS.W. LinK.L. KisaluN.K. HensleyL.E. RimoinA.W. Cytokine modulation correlates with severity of monkeypox disease in humans.J. Clin. Virol.201563424510.1016/j.jcv.2014.12.001 25600603
     [Google Scholar]
  31. NagataN. SaijoM. KataokaM. AmiY. SuzakiY. SatoY. Iwata-YoshikawaN. OgataM. KuraneI. MorikawaS. SataT. HasegawaH. Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey.Int. J. Clin. Exp. Pathol.20147743594370 25120821
     [Google Scholar]
  32. DwivediS. Human monkeypox virus and host immunity: New challenges in diagnostics and treatment strategies.Adv. Exp. Med. Biol.2024145121923710.1007/978‑3‑031‑57165‑7_14 38801581
     [Google Scholar]
  33. AtkinsonJ.P. 21 - The human complement system: Basic concepts and clinical relevance. Clinical Immunology.5th edLondonElsevier201929931710.1016/B978‑0‑7020‑6896‑6.00021‑1
     [Google Scholar]
  34. LiszewskiM.K. LeungM.K. HauhartR. BullerR.M.L. BertramP. WangX. RosengardA.M. KotwalG.J. AtkinsonJ.P. Structure and regulatory profile of the monkeypox inhibitor of complement: Comparison to homologs in vaccinia and variola and evidence for dimer formation.J. Immunol.200617663725373410.4049/jimmunol.176.6.3725 16517741
     [Google Scholar]
  35. Mpox2024Available from: https://www.who.int/news-room/fact-sheets/detail/mpox
  36. KalerJ. HussainA. FloresG. KheiriS. DesrosiersD. Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation.Cureus2022147e2653110.7759/cureus.26531 35928395
     [Google Scholar]
  37. RizkJ.G. LippiG. HenryB.M. ForthalD.N. RizkY. Prevention and treatment of monkeypox.Drugs202282995796310.1007/s40265‑022‑01742‑y 35763248
     [Google Scholar]
  38. AlmehmadiM. AllahyaniM. AlsaiariA.A. AlshammariM.K. AlharbiA.S. HussainK.H. AlsubaihiL.I. KamalM. AlotaibiS.S. AlotaibiA.N. AldhafeeriA.A. ImranM. A glance at the development and patent literature of tecovirimat: The first-in-class therapy for emerging monkeypox outbreak.Viruses2022149187010.3390/v14091870 36146675
     [Google Scholar]
  39. SiegristE.A. SassineJ. Antivirals with activity against mpox: A clinically oriented review.Clin. Infect. Dis.202376115516410.1093/cid/ciac622 35904001
     [Google Scholar]
  40. ChamberlainJ.M. Cidofovir diphosphate inhibits adenovirus 5 DNA polymerase via both nonobligate chain termination and direct inhibition, and polymerase mutations confer cidofovir resistance on intact virus.Antimicrob. Agents Chemother.2018631e01925e1810.1128/AAC.01925‑18 30397065 PMC6325223
     [Google Scholar]
  41. SahR. HumayunM. BaigE. FarooqM. HussainH.G. ShahidM.U. CheemaH.A. ChandranD. YatooM.I. SharmaA.K. DhamaK. FDA’s authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; An update – Correspondence.Int. J. Surg.202210710697110.1016/j.ijsu.2022.106971 36330988
     [Google Scholar]
  42. GuarnerJ. del RioC. MalaniP.N. Monkeypox in 2022 — What clinicians need to know.JAMA2022328213914010.1001/jama.2022.10802 35696257
     [Google Scholar]
  43. Jacob-DolanC. TyD. HopeD. McMahanK. LiuJ. PowersO.C. CotterC.A. SciaccaM. WuC. BorducchiE. BouffardE. RichterH. VelascoJ. TeowE. BoursiquotM. CookA. FelicianoK. Yalley-OgunroJ. SeamanM.S. PessiantL. LewisM.G. AndersenH. MossB. BarouchD.H. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.Sci. Transl. Med.202416740eadl431710.1126/scitranslmed.adl4317 38536937
     [Google Scholar]
  44. MazzottaV. MatusaliG. OlivaA. MaggiF. AntinoriA. Progress in the evaluation of modified vaccinia Ankara vaccine against Mpox.Lancet Infect. Dis.202323111214121510.1016/S1473‑3099(23)00369‑9 37475114
     [Google Scholar]
  45. KatameshB.E. MadanyM. LabiebF. AbdelaalA. Monkeypox pandemic containment: Does the ACAM2000 vaccine play a role in the current outbreaks?Expert Rev. Vaccines202322136636810.1080/14760584.2023.2198600 37017380
     [Google Scholar]
  46. MeoS.A. Al-MasriA.A. KlonoffD.C. AlshahraniA.N. Al-khlaiwiT. Comparison of biological, pharmacological characteristics, indications, contraindications and adverse effects of JYNNEOS and ACAM2000 monkeypox vaccines.Vaccines20221011197110.3390/vaccines10111971 36423066
     [Google Scholar]
  47. KandeelM. MorsyM.A. Abd El-LateefH.M. MarzokM. El-BeltagiH.S. Al KhodairK.M. AlbokhadaimI. VenugopalaK.N. Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention.Int. Immunopharmacol.202311911020610.1016/j.intimp.2023.110206 37087871
     [Google Scholar]
  48. de JongeE.F. PeterseC.M. KoelewijnJ.M. van der DriftA.M.R. van der BeekR.F.H.J. NagelkerkeE. LodderW.J. The detection of monkeypox virus DNA in wastewater samples in the Netherlands.Sci. Total Environ.202285215826510.1016/j.scitotenv.2022.158265 36057309
     [Google Scholar]
  49. CyrklaffM. RiscoC. FernándezJ.J. JiménezM.V. EstébanM. BaumeisterW. CarrascosaJ.L. Cryo-electron tomography of vaccinia virus.Proc. Natl. Acad. Sci. USA200510282772277710.1073/pnas.0409825102 15699328
     [Google Scholar]
/content/journals/aia/10.2174/0122113525395043250625113321
Loading
MPOX: A Re-Emerging Zoonotic Orthopoxvirus Threatening Global Health
Anti Infect. Agents 24, E22113525395043 (2026); https://doi.org/10.2174/0122113525395043250625113321
/content/journals/aia/10.2174/0122113525395043250625113321
/content/journals/aia/10.2174/0122113525395043250625113321
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): DNA replication; lesions; lymphadenopathy; Monkeypox; zoonotic virus

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test